Skip to main content
Clinical Trials/NCT02609802
NCT02609802CompletedPhase 3

The Different Analgesic Potency of Sevoflurane and Desflurane at Equi-minimum Alveolar Concentration

Kangbuk Samsung Hospital1 site in 1 country77 target enrollmentStarted: November 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
77
Locations
1
Primary Endpoint
Analgesic potency of volatile anesthetics

Study Overview

Brief Summary

The aim of this clinical trial is to evaluate the difference of analgesic potency of sevoflurane and desflurane at equi-minimum alveolar concentration using a surgical pleth index.

Detailed Description

Volatile anesthetics vary in their relative hypnotic potencies. Recent studies demonstrated that equi-minimum alveolar concentration of various volatile anesthetics produced different EEG-derived indices such as bispectral index. However, there was no controlled study that demonstrates the difference of analgesic potency. The aim of this clinical trial is to evaluate the difference of analgesic potency of sevoflurane and desflurane at equi-minimum alveolar concentration using a surgical pleth index.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
19 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients undergoing arthroscopic shoulder surgery
  • patients with american society of anesthesiologist physical status I, II
  • patients aged 19-65 years
  • patients obtaining written informed consent

Exclusion Criteria

  • patients with a history of any psychiatric or neurological disease
  • patients who had received any medication affecting the central nervous system
  • patients who had received medication affecting the sympathetic or parasympathetic nervous systems
  • patients who have not received interscalene approach brachial plexus block (refusal or failure)
  • pregnant women

Arms & Interventions

Sevoflurane

Experimental

Anesthesia was maintained with sevoflurane.

Intervention: Sevoflurane (Drug)

Desflurane

Experimental

Anesthesia was maintained with desflurane.

Intervention: Desflurane (Drug)

Outcomes

Primary Outcomes

Analgesic potency of volatile anesthetics

Time Frame: the first 60 min of maintaining a steady state 1 MAC of volatile agents

The analgesic potency was evaluated by surgical pleth index value

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Kangbuk Samsung Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kyoungho Ryu

Clinical assistant professor

Kangbuk Samsung Hospital

Study Sites (1)

Loading locations...

Similar Trials

The Different Analgesic Potency of... | Clinical Trial